• Akebia Therapeutics' (AKBA) "Buy" Rating Reaffirmed at HC Wainwright

    المصدر: Buzz FX / 15 مارس 2025 08:54:17   America/Chicago


    Akebia Therapeutics' (AKBA) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Akebia Therapeutics ( NASDAQ:AKBA - Get Free Report ) 's stock had its "buy" rating restate
    Read more...
شارك على،